A biologic candidate's path from DNA to drug-in-vial is long and complex. These considerations might simplify and improve the economics of the process, helping molecules get to market as quickly as possible.
Hiring bioprocessing pros has been a stubborn problem for more than a decade, challenging startup companies as the supply of qualified staff gets tighter. Here's how the industry could solve the problem.
The journey from large molecule to approved biotherapeutic is long, costly, complex, and fraught with risk — yet the rewards for success are substantial. Knowing what to expect and where to go, and to whom, for guidance can provide the confidence that you're on the right track and help to accelerate the journey.
Media selection is a crucial step in optimizing and maximizing your upstream process. Mixing media and feeds can be a strategy in fed batch to increase output of your target molecule. Learn more about our Cellvento® and EX-CELL® cell culture media brands.